O
Oriol Mitjà
Researcher at International SOS
Publications - 134
Citations - 3882
Oriol Mitjà is an academic researcher from International SOS. The author has contributed to research in topics: Medicine & Population. The author has an hindex of 25, co-authored 96 publications receiving 2259 citations. Previous affiliations of Oriol Mitjà include Global Hospitals Group & University of Vic.
Papers
More filters
Journal ArticleDOI
Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study.
Michael Marks,Michael Marks,Pere Millat-Martinez,Dan Ouchi,Chrissy h. Roberts,Andrea Alemany,Marc Corbacho-Monné,Maria Ubals,Aurelio Tobias,Cristian Tebé,Ester Ballana,Quique Bassat,Bàrbara Baro,Martí Vall-Mayans,Camila G-Beiras,Nuria Prat,Jordi Ara,Bonaventura Clotet,Oriol Mitjà +18 more
TL;DR: In this paper, the authors analyzed data from linked index cases of COVID-19 and their contacts to explore the factors associated with transmission of SARS-CoV-2.
Journal ArticleDOI
Clinical presentation and virological assessment of confirmed human monkeypox virus cases in Spain: a prospective observational cohort study
E. Tarín-Vicente,Andrea Alemany,M. Agud‐Dios,María Ubals,Clara Suñer,Andrés Antón,Maider Arando,Jorge Arroyo-Andrés,L. Calderón-Lozano,Cristina Casañ,José Miguel Cabrera,Pep Coll,Vicente Descalzo,María Dolores Folgueira,Jorge N. Garcia-Pérez,Elena Gil-Cruz,B. González Rodríguez,C. Gutiérrez-Collar,Agueda Hernandez-Rodriguez,Paula López-Roa,María de los Ángeles Meléndez,J. Montero-Menárguez,Irene Muñoz-Gallego,Sara Isabel Palencia-Pérez,Roger Paredes,Alfredo Pérez-Rivilla,Maria Piñana,Nuria Prat,Aida Contreras Ramírez,Ángel J. Gordillo Rivero,C.A. Rubio‐Muniz,Marti Vall,Kevin Stephen Acosta-Velásquez,An-liu Wang,Cristina Galván-Casas,Michael Marks,Pablo L. Ortiz-Romero,Oriol Mitjà +37 more
TL;DR: In this cohort, monkeypox caused genital, perianal, and oral lesions and complications including proctitis and tonsillitis, which suggests close contact is probably the dominant transmission route in the current outbreak.
Journal ArticleDOI
Hydroxychloroquine for Early Treatment of Adults with Mild Covid-19: A Randomized-Controlled Trial.
Oriol Mitjà,Marc Corbacho-Monné,Maria Ubals,Cristian Tebé,Judith Peñafiel,Aurelio Tobias,Ester Ballana,Andrea Alemany,Núria Riera-Martí,Carla A. Pérez,Clara Suñer,Pep Laporte,Pol Admella,Jordi Mitjà,Mireia Clua,Laia Bertran,Maria Sarquella,Sergi Gavilán,Jordi Ara,Josep M. Argimon,Jordi Casabona,Gabriel Cuatrecasas,Paz Cañadas,Aleix Elizalde-Torrent,Robert Fabregat,Magí Farré,Anna Forcada,Gemma Flores-Mateo,Esteve Muntada,Núria Nadal,Silvia Narejos,Aroa N Gil-Ortega,Nuria Prat,Jordi Puig,Carles Quiñones,Juliana Reyes-Ureña,Ferran Ramírez-Viaplana,Lidia Ruiz,Eva Riveira-Muñoz,Alba Sierra,César Velasco,Rosa Maria Vivanco-Hidalgo,Alexis Sentís,Camila G-Beiras,Bonaventura Clotet,Martí Vall-Mayans +45 more
TL;DR: In patients with mild Covid-19, no benefit was observed with HCQ beyond the usual care and the time to complete resolution of symptoms was shortened.
Journal ArticleDOI
Use of antiviral drugs to reduce COVID-19 transmission.
Oriol Mitjà,Bonaventura Clotet +1 more
TL;DR: A Pharmacological model ling based on observed drug concentrations and in vitro drug testing suggest that prophylaxis with hydroxychloroquine at approved doses could prevent SARS-CoV-2 infection and ameliorate viral shedding.
Journal ArticleDOI
Review: Hydroxychloroquine and chloroquine for treatment of SARS-CoV-2 (COVID-19)
Katelyn A Pastick,Elizabeth C Okafor,Fan Wang,Sarah M Lofgren,Caleb P Skipper,Melanie R. Nicol,Matthew F Pullen,Radha Rajasingham,Emily G. McDonald,Todd C. Lee,Ilan S. Schwartz,Lauren E. Kelly,Sylvain A. Lother,Oriol Mitjà,Emili Letang,Mahsa Abassi,David R. Boulware +16 more
TL;DR: A rapid narrative review and call for additional randomized controlled trial evidence prior to the widespread incorporation of hydroxychloroquine and chloroquine into national and international treatment guidelines are called for.